{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:53:29Z","timestamp":1768434809269,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.cca.2022.06.017","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T01:56:09Z","timestamp":1655862969000},"page":"122-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Optimization of the cut-offs in acetylcholine receptor antibodies and diagnostic performance in myasthenia gravis patients"],"prefix":"10.1016","volume":"533","author":[{"given":"Kai","family":"Shao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Xian","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Jun","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Jun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan-Zhu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.cca.2022.06.017_b0005","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia Gravis","volume":"375","author":"Longo","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.cca.2022.06.017_b0010","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0022-510X(83)90096-5","article-title":"Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 2. Clinical and serological follow-up of individual patients","volume":"58","author":"Oosterhuis","year":"1983","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.cca.2022.06.017_b0015","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/jnnp.56.5.496","article-title":"Clinical implementation of anti-acetylcholine receptor antibodies","volume":"56","author":"Somnier","year":"1993","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"10.1016\/j.cca.2022.06.017_b0020","first-page":"289","article-title":"Relationship between anti-acetylcholine receptor antibody titres and severity of myasthenia gravis","volume":"59","author":"Aurangzeb","year":"2009","journal-title":"J. Pak. Med. Assoc."},{"key":"10.1016\/j.cca.2022.06.017_b0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/CND.0b013e31824619d5","article-title":"The quantitative myasthenia gravis score: comparison with clinical, electrophysiological, and laboratory markers","volume":"13","author":"Barnett","year":"2012","journal-title":"J. Clin. Neuromuscul. Dis."},{"issue":"1-2","key":"10.1016\/j.cca.2022.06.017_b0030","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2014.05.037","article-title":"Clinical and serological study of myasthenia gravis using both radioimmunoprecipitation and cell-based assays in a South Asian population","volume":"343","author":"Chang","year":"2014","journal-title":"J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.cca.2022.06.017_b0035","doi-asserted-by":"crossref","first-page":"e114060","DOI":"10.1371\/journal.pone.0114060","article-title":"Repeated acetylcholine receptor antibody-concentrations and association to clinical myasthenia gravis development","volume":"9","author":"Heldal","year":"2014","journal-title":"PLoS. One."},{"issue":"4","key":"10.1016\/j.cca.2022.06.017_b0040","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/mus.23944","article-title":"Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis","volume":"49","author":"Sanders","year":"2014","journal-title":"Muscle. Nerve."},{"issue":"1-2","key":"10.1016\/j.cca.2022.06.017_b0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cccn.2005.05.035","article-title":"A sensitive non-isotopic assay for acetylcholine receptor autoantibodies","volume":"364","author":"Hewer","year":"2006","journal-title":"Clin. Chim. Acta."},{"issue":"1","key":"10.1016\/j.cca.2022.06.017_b0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ana.10400","article-title":"Treatment of refractory myasthenia: \u201crebooting\u201d with high-dose cyclophosphamide","volume":"53","author":"Drachman","year":"2003","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.cca.2022.06.017_b0055","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/1756285611411503","article-title":"Response of patients with refractory myasthenia gravis to rituximab: a retrospective study","volume":"4","author":"Nowak","year":"2011","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"6","key":"10.1016\/j.cca.2022.06.017_b0060","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/mus.26300","article-title":"Factors predicting remission in thymectomized patients with acetylcholine receptor antibody-positive myasthenia gravis","volume":"58","author":"Kim","year":"2018","journal-title":"Muscle. Nerve."},{"issue":"7","key":"10.1016\/j.cca.2022.06.017_b0065","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.autrev.2010.12.007","article-title":"Factors implicated in the generation and persistence of long-lived plasma cell-mediated autoimmunity","volume":"10","author":"Neves","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cca.2022.06.017_b0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneuroim.2016.07.001","article-title":"Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients","volume":"298","author":"Hong","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.cca.2022.06.017_b0075","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/ene.13300","article-title":"Multiple antibody detection in 'seronegative' myasthenia gravis patients","volume":"24","author":"Hong","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.cca.2022.06.017_b0080","doi-asserted-by":"crossref","unstructured":"C.M. Gambino, L. Agnello, B. Lo Sasso, et al., Comparative Analysis of BIOCHIP Mosaic-Based Indirect Immunofluorescence with Enzyme-Linked Immunosorbent Assay for Diagnosing Myasthenia Gravis, Diagnostics. (Basel), 11 (2021) 2098. https:\/\/doi.org\/10.3390\/diagnostics11112098.","DOI":"10.3390\/diagnostics11112098"},{"key":"10.1016\/j.cca.2022.06.017_b0085","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/labmed\/lmy038","article-title":"Rapid and Non-Radiolabeled Immune Assay to Detect Anti-AChR Antibodies in Myasthenia Gravis","volume":"50","author":"Bokoliya","year":"2019","journal-title":"Lab. Med."},{"key":"10.1016\/j.cca.2022.06.017_b0090","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/clinchem\/36.6.911","article-title":"Improved radioassay of anti-acetylcholine receptor antibody: application for the detection of extremely low antibody titers in sera from patients with myasthenia gravis","volume":"36","author":"Ohta","year":"1990","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2022.06.017_b0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jneuroim.2011.09.007","article-title":"Development of a highly sensitive diagnostic assay for muscle-specific tyrosine kinase (MuSK) autoantibodies in myasthenia gravis","volume":"240\u2013241","author":"Trakas","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.cca.2022.06.017_b0100","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mus.880090505","article-title":"Antimuscle and antiacetylcholine receptor antibodies in myasthenia gravis","volume":"9","author":"Penn","year":"1986","journal-title":"Muscle. Nerve."},{"issue":"1-2","key":"10.1016\/j.cca.2022.06.017_b0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cccn.2004.05.008","article-title":"Muscle-specific receptor tyrosine kinase autoantibodies\u2013a new immunoprecipitation assay","volume":"348","author":"Matthews","year":"2004","journal-title":"Clin. Chim. Acta."},{"issue":"20","key":"10.1016\/j.cca.2022.06.017_b0110","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1212\/WNL.0b013e31825644ff","article-title":"Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients","volume":"78","author":"Leite","year":"2012","journal-title":"Neurology."},{"key":"10.1016\/j.cca.2022.06.017_b0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.clineuro.2014.07.036","article-title":"Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature","volume":"125","author":"Ikeguchi","year":"2014","journal-title":"Clin. Neurol. Neurosurg."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122012074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122012074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:05:43Z","timestamp":1757862343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898122012074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":23,"alternative-id":["S0009898122012074"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2022.06.017","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of the cut-offs in acetylcholine receptor antibodies and diagnostic performance in myasthenia gravis patients","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2022.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}